|
Boston Scientific has begun to restructure its leadership team and modify the organization--including significant changes to its international headquarters in Natick, Mass.--and initiated layoffs of 8 to 10 percent of its non-direct labor base.
Medtronic has commenced the U.S. market launch of its Talent thoracic stent graft on the Xcelerant delivery system for minimally invasive treatment of thoracic aortic aneurysms.
Medtronic (Booth 826) is highlighting its Talent and Endurant endovascular stent graft systems.
The FDA has granted approval for Medtronic’s Talent thoracic stent
graft, a medical device that will allow more patients to benefit from a
minimally invasive treatment for certain types of aneurysms of the
descending thoracic aorta.
|
The United States Court of Appeals for the Federal Circuit affirmed a previous ruling of the United States District Court for the Northern District of California that Cook Medical and Newark, Del.-based W.L. Gore & Associates do not infringe on Edwards Lifesciences’ patents for endovascular devices to treat aneurysms.
Genesis Medical Interventional (Booth 1405) and its licensing partner,
Micrus Endovascular, are highlighting Genesis’ F.A.S.T. Funnel Catheter
and clot retrieval system for the treatment of ischemic stroke.
Vascular Solutions (Booth 1003) is unveiling medical devices designed
for the retrieval and manipulation of objects located in the
cardiovascular system, including coils, balloons, catheters and
guidewires.
|
RSS 
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).